-
Meet poster presenters and explore the Exhibit Hall on Sunday
Poster presenters will be available for discussion at their poster boards during Sunday’s General Poster Session. Industry representatives also will be in the Exhibit Hall from 10:00 a.m. – 4:00 p.m.
-
Diabetes symposium will elucidate the key role of the central nervous system in metabolic control
“The role of the central nervous system (CNS) in metabolic regulation has important implications for normal physiology and for disease, and this symposium was constructed to highlight how these may contribute to diabetes,” said Diabetes® Editor in Chief David A. D’Alessio, MD.
-
Session to outline nutrition interventions that work
Gamification, prescriptions for fresh produce, and nutrition education have proven successful components to diabetes prevention and treatment. Panelists including Grace E. Shearrer, PhD, will explain how these concepts have been put into action in the real world.
-
Panel will address issues and challenges around CGM use in pregnancy
A Sunday symposium will explore evolving evidence for CGM use in pregnancy. Sarit Polsky, MD, MPH, one of the expert panelists, will compare time in range versus conventional fasting and postprandial targets in pregnancy.
-
Symposium will examine mechanisms of GLP-1/GIP-mediated metabolic regulation and side effects of GLP-1/GIP-based therapies
Dual agonists of the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) have taken center stage in the treatment of obesity and type 2 diabetes. Experts, including Timo D. Müller, PhD, will explore GLP-1/GIP-mediated energy metabolism.
-
Researchers highlight complicated dynamics of SARS-CoV-2 and type 1 diabetes
Carmella Evans-Molina, MD, PhD, and Peter K. Jackson, PhD, presented differing views on whether COVID-19 infection can cause type 1 diabetes in a debate on the opening day of the 84th Scientific Sessions in Orlando.
-
Experts will discuss evolving paradigms and evidence on kidney disease in diabetes
Diabetes is the leading cause of kidney disease and kidney failure. Panelists including Andrew Advani, BSc, MBChB(Hons), PhD, FRCP(UK), FRCP(Edin), FASN, will explore shifting disease management strategies.
-
Panel to explore ongoing evolution of behavioral care in diabetes
One of the featured panelists, Gretchen Piatt, PhD, MPH, says the fundamental tenets of patient empowerment, including patient-centered care and autonomous decision-making, remain integral to the practice of behavioral diabetes care.
-
ADA’s National Health Disparities Committee awards top 10 health disparities-related abstracts of Scientific Sessions
These abstracts focus on health care disparities in diabetes outcomes, showcase research that explores the underlying factors in diabetes disparities, and demonstrate practical interventions that may contribute to eliminating those disparities.
-
Innovation Challenge, 5K@ADA group run among special events on Saturday
The Innovation Challenge, Exhibit Hall demonstrations, 5K@ADA Virtual Challenge, Poster Hall displays, and more supplement the scientific program taking place on Saturday.